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Distinguishing Ewing sarcoma 
and osteomyelitis using FTIR 
spectroscopy
Radosław Chaber1, Christopher J. Arthur2, Joanna Depciuch3, Kornelia Łach1, 
Anna Raciborska4, Elżbieta Michalak5 & Józef Cebulski6
The differential diagnosis of Ewing sarcoma and osteomyelitis can be challenging and can lead to 
delays in treatment with possibly devastating results. In this retrospective, small-cohort study we 
demonstrate, that the Fourier Transformed Infrared (FTIR) spectra of osteomyelitis bone tissue can be 
differentiated from Ewing sarcoma and normal bone tissue sampled outside tumour area. Significant 
differences in osteomyelitis samples can be seen in lipid and protein composition. Supervised learning 
using a quadratic discriminant analysis classifier was able to differentiate the osteomyelitis samples 
with high accuracy. FTIR spectroscopy, alongside routine radiological and histopathological methods, 
may offer an additional tool for the differential diagnosis of osteomyelitis and ES.
Ewing sarcoma (ES) is a poorly differentiated tumour of bones or soft tissues derived from primitive mesenchy-
mal stem cells. This tumour is the second most common bone malignancy with 2.9 cases per million population 
(below the age of 20). With advances in multimodal therapy, survival rates for patients with localized disease 
approach 70%. Patients with metastatic, refractory, or relapsed disease, however, have a poor outcome (5-yrs. 
overall survival about 42%)1. Unfortunately, misdiagnosis of Ewing Sarcoma and the bone disease osteomyelitis 
is well-reported due to the similarities in their presentation. In both delayed or misdiagnosis can lead to adverse 
clinical outcomes.
Osteomyelitis arises because of infection of the bone with bacteria being the usual etiologic agents (most 
commonly Staphylococcus aureus). In children, osteomyelitis is primarily of haematogenous origin, occurring 
less commonly as a result of trauma, surgery, or infected contiguous soft tissue2. Acute osteomyelitis affects about 
8 children per 100,000 children/year3. Children under 5 years of age are affected in about 50% of the cases, with 
a male/female ratio of 2:1. Acute osteomyelitis is approximately twice as common as septic arthritis, and its inci-
dence is steadily increasing (due in part to the growing frequency of antibiotic resistance amongst Staphylococci)3.
The similarity of the clinical course and the radiological and histopathological picture of ES and osteomy-
elitis makes it difficult to distinguish these two diseases objectively. Although open biopsy may provide a better 
diagnostic yield, it has limitations, particularly in patients with ES. McCarville et al. suggest that when an open 
biopsy is not diagnostic, such patients are more likely to harbour a malignancy than an infection and it is thus 
recommended to perform a repeat biopsy to initiate appropriate therapy4. Given the challenge of differentiating 
these two conditions, it is essential that new diagnostic methods can be discovered that can aid diagnosis in cases 
where the diagnosis is in doubt.
Fourier Transform Infrared (FTIR) spectroscopy has emerged in recent years as a promising tool for the 
study and diagnosis of disease. FTIR measures the absorption of infrared radiation by the chemical bonds in 
constituent molecules of a sample. It therefore provides bulk information about the biochemical composition 
of a sample as opposed to immunohistochemistry or other molecular techniques that selectively target specific 
macromolecule types5. Despite this lack of selectivity, FTIR is advantageous due to its small sample size (a few 
micrograms) and the limited requirements on the sample (tissue) pre-processing (e.g., demineralization, staining, 
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deparrafinization)6. As such, FTIR spectroscopy can be applied to early stages of a disease, before tissue changes 
are detectable by light microscopy. FTIR has also been used to monitor disease course and therapeutic outcome7. 
In addition to this clinical utility, FTIR spectroscopy is rapid, inexpensive and straightforward to perform. The 
FTIR features of Ewing sarcoma infected bone tissue have been previously reported8, however to-date no study 
has reported the FTIR spectroscopic features of osteomyelitis nor compared those with Ewing Sarcoma to deter-
mine whether they differ.
In view of the importance of misdiagnosis of osteomyelitis and ES on patient outcomes we sought to inves-
tigate the diagnostic potential of FTIR spectroscopy in differentiating these two clinically important diseases. 
To that end we report the analysis of bone tissue from patients with ES or osteomyelitis using ATR-FTIR and 
statistical methods.
Materials and Methods
Patients. Samples of bone tissue were obtained from 27 patients with ES (aged 5–20 years old with a median 
age of 14, male/female ratio of 12/15) and 10 patients with osteomyelitis (age 2–17 years old with a median age 
of 11 years and a male/female ratio of 6/4). Samples were allocated to three study groups: group I – normal bone 
tissue sampled outside the area of ES infiltration after neoadjuvant chemotherapy completion (20 samples), group 
II – osteomyelitis bone tissues (10 samples) and 27 ES bone tissues collected during a diagnostic biopsy (group 
III). The samples in the first group were collected from ES patients. Surgery was performed at the Department of 
Surgical Oncology, Institute of Mother and Child in Warsaw, Poland. Each histopathological sample was verified 
at the same institution by pathologists experienced in bone disorders.
The study was conducted under Institutional Review Board (Protocol No. KBET/6/06/2014) from June 2014 
at University of Rzeszow. The experimental protocols used in this study were approved by the institutional ethics 
committees (IECs) of the University of Rzeszow and were carried out in accordance with the approved guidelines. 
Informed consent was obtained from all patients or their guardians before treatment.
Samples preparation for FTIR measurements.  Samples were prepared for FTIR measurement accord-
ing to the procedure of Depciuch et al.9. The bone tissue specimens were placed for about 12 h in liquid fixative. 
Afterwards, the ethanol content within the tissue was gradually replaced with xylene, starting from 50%, then 
70%, 80%, 90% and 96%, up to anhydrous (absolute 99.8% of xylene). Then the samples were rinsed with distilled 
water and dried. Each incubation step was performed for 5 min. Such Formalin-fixed paraffin-embedded (FFPE) 
bone tissue specimens were then cut into 10 μm thick sections using a rotary microtome. FFPE tissue sections 
were then applied to calcium fluoride (CaF2) slides.
FTIR Spectroscopy.  FTIR spectra were recorded using a Vertex 70v Fourier transform infrared spectrom-
eter (Bruker). Tissue specimens were directly applied to the attenuated total reflection (ATR) diamond crystal 
and spectra in the mid-infrared range were recorded (32 scans with 2 cm−1 of spectral resolution). As the samples 
were dewaxed, the air was measured as the background. All measurements were recorded in triplicate. Data anal-
ysis was performed using the program OPUS 7.0 from Bruker Optik GmbH 2011. Spectra were mean centred, 
scaled to unit variance, smoothed using a Savitzky–Golay filter and a linear detrend applied.
Deconvolution of amide I region (1600–1700 cm−1). Protein secondary structure was analysed by 
means of curve fitting using MagicPlot 2.7.2. First, the second derivative spectra were determined based on the 
ATR-FTIR spectra to determine the initial peak positions for curve fitting, and the peaks were fitted using a 
Gaussian function. The sum of value of all maxima absorbance corresponding to α-helix and β-sheet was consid-
ered 100% and each component (separately for α-helix and β-sheet) was expressed as its percentage after fitting.
Statistics.  The data were analysed using the one-way ANOVA followed by the Tukey’s test. A p-value < 0.05 
was considered statistically significant with the 95% confidence interval (MatLab).
Data analysis. For all obtained spectra, vector normalization and baseline correction were applied. These 
operations were performed using OPUS 7.0 software. Moreover, in each FTIR spectrum, a vibrations corre-
sponding to nucleic acid, phospholipids, proteins, lipids, were analysed. The number of obtained data from FTIR 
therefore, to determine a similarity between analysed three groups, a PCA analysis, was done. PCA reduces the 
dimensionality, the number of variables of the data, by maintaining as much variance as possible. This analysis 
was done using Past software. Moreover, to determine the similarity between samples within the groups, as well 
as between I, II and III groups, a hierarchical cluster analysis (HCA) using Past software, were done. Further data 
analysis including clustering and dimensionality reduction was performed using Python 3.6 and Scikit Learn 
0.19.1.
Compliance with ethical standards. All procedures performed in studies involving human participants 
were in accordance with the ethical standards of the institutional and/or national research committee and with 
the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved 
by the Committee for Research Ethics of University of Rzeszow (decision 6/06/2014).
Approval. All experimental protocols were approved by a named institutional.
Accordance. The methods were carried out in accordance with the relevant guidelines and regulations. 
Informed consent was obtained from all individual participants included in the study. All data is availability.
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Results
As expected, peaks corresponding to functional groups within nucleic acids, phospholipids, polysaccharides, 
proteins and lipids are observable in the FTIR spectra of bone tissues (Fig. 1). The peak positions along with their 
maximum absorbance for the average FTIR spectra with corresponding vibrations are described in Table 1.
Visible shifts of the peaks between osteomyelitis and ES bone tissue spectra compared to normal bone tissue 
sampled outside the area of ES infiltration could be observed. Moreover, shifts of the peaks between osteomyelitis 
and ES bone tissue could also be seen. Moreover, the changes in the FTIR range corresponding to amide II vibra-
tions, were significantly different between osteomyelitis and ES bone tissue as well as normal bone tissue sampled 
outside the area of ES infiltration.
The maximal absorbance values of individuals are similar in each group, whilst between groups differences 
can be discerned. The most visible differences in the values of absorbance in wavenumbers corresponding to 
DNA, phospholipids, amide II and lipids, were observed. The highest value of absorbance of peak at 1029 cm−1 
in the FTIR spectrum of normal bone tissue sampled outside the area of ES infiltration, were observed, while the 
lowest value of absorbance of this peak in the FTIR spectrum of osteomyelitis bone tissue, were visible. In the 
in the FTIR spectrum of osteomyelitis tissue, however, the absorbance at 1540 cm−1, was greatest, whilst in the 
FTIR spectra of the ES bone tissue, the highest value of peaks at 2848 cm−1, 2916 cm−1, 2956 cm−1, were observed.
Deconvolution of the amide I region allows information about the type of secondary structure to be obtained, 
as well as the changes in the values of α-helix and β-sheet in proteins to be monitored (Fig. 3). The peaks between 
1600–1640 cm−1 and between 1670–1700 cm−1 corresponding to the secondary structure of proteins vibrations of 
β-sheet and β-turn, respectively. Furthermore, the IR range around 1650 cm−1 originates from α-helix10.
A different number of band components are observable in the three analysed groups (Fig. 2): with seven band 
components in the normal bone tissue, eight in the ES bone tissue and ten components in the osteomyelitis bone 
Figure 1. Normalised average FTIR spectra of normal bone tissue sampled outside the area of ES infiltration 
(black), osteomyelitis bone tissue (blue) and ES bone tissue (red).
FTIR spectroscopy peaks (cm−1)
normal bone tissue 
sampled outside the 
area of ES infiltration
Osteomyelitis bone 
tissue ES bone tissue
AssignmentPeaks Max. (a.u.) Peaks
Max. 
(a.u.) Peaks
Max. 
(a.u.)
1029 0.421 1041 0.992 1059 0.041 PO3−2 group from DNA, RNA and phospholipids23
1162 0.074 1170 0.011 1169 0.012 C-O group from groups of serine, threonine, and tyrosine of protein24
1234 0.312 1250 0.031 1238 0.312 Amide III25
1337 0.008 1320 0.008 1342 0.011 CH2 group from protein25
1396 0.010 1380 0.010 1382 0.012 Possible carbonate band ʋ2 (CO32−)23
1462 1.412 1465 1.413 1467 1.412 CH2 group from cholesterol23
1540 1.761 1542 1.932 1551 1.763 Amide II26
1635 2.000 1649 2.102 1657 2.000 Amide I26
1740 −1.251 1740 −0.091 1740 −1.251 C=O stretching vibrations from aldehyde27
2848 2.402 2858 2.102 2848 2.913 symmetric stretching vibrations of CH227
2916 4.098 2910 3.213 2906 4.201 asymmetric stretching vibrations of CH227
2956 0.123 2958 0.123 2958 0.123 asymmetric stretching vibrations of CH327
3283 0.013 3295 0.003 3289 0.012 ʋ-NH stretching of the peptide bond (-NHCO) of proteins
28 
and ʋ-OH stretching of functional groups of water29
Table 1. FTIR peaks position with corresponding vibrations in analysed three groups23–29.
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tissues. In the next step, the α-helix - β-sheet ratio was calculated from the deconvolution of amide I FTIR range 
(Table 2). The ratio of secondary protein structure is significantly lower in ES and osteomyelitis bone tissues com-
pared to normal bone tissue. Moreover, the calculated ratio for ES bone tissue and osteomyelitis bone tissues, also 
differed but without statistical significance.
We then turned our attention to whether it is possible to differentiate the ES samples from the osteomyelitis 
samples and turned in the first instance to unsupervised dimensionality reduction via principal components 
analysis (PCA). Dimensionality reduction is broadly based on the selection of the informative features or on the 
synthesis of variables that retain the information present in the original dataset. In principal component analysis 
this dimensionality reduction is achieved by finding the linear combination of a set of variables that has max-
imum variance. When the spectral dataset was analysed by PCA (Fig. 3a), although the osteomyelitis samples 
(blue) clustered together to some extent there was considerable overlap between all three tissue classes.
More recent methods for dimensionality reduction, particularly non-linear (manifold) methods, have 
emerged which we speculated may allow the tissue classes to be differentiable. A suite of dimensionality reduction 
methods, including both matrix deconvolution and manifold learning methods as implemented in the python 
library Scikit Learn, were applied (as shown in Fig. 3). Many of these methods afforded greater visual separation 
of the classes than PCA. Of note is t-distributed stochastic neighbour embedding (t-SNE, Fig. 3o), which resulted 
Figure 3. Dimensionality reduction methods applied to the FTIR dataset. Matrix decomposition methods 
(a). PCA (b). Factor analysis (c). Fast Independent Components Analysis (FastICA) (d). Incremental PCA (e). 
Truncated singular value decomposition (SVD) (f). Kernel PCA using a linear kernel. (g) Kernel PCA using a 
sigmoid kernel. (h). Kernel PCA using a polynomial kernel. (i). Kernel PCA using a radial basis function kernel. 
(j). Kernel PCA using a cosine kernel. Manifold Learning methods (k). Locally linear embedding. (l) Isomap 
(m). Multidimensional scaling (MDS) (n). Spectral embedding and (o). t-distributed stochastic neighbour 
embedding (t-SNE).
Figure 2. Deconvolution of amide I FTIR region (1700–1600 cm−1) obtained for three analysed groups: normal 
bone tissue sampled outside the area of ES infiltration (a) ES bone tissue (b) osteomyelitis bone tissue (c). The 
peaks for calculated α-helix - β-sheet ratio are indicated.
www.nature.com/scientificreports/
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in clear clustering of the osteomyelitis bone spectra. All methods struggled to discriminate between the normal 
and ES samples although t-SNE shows some clustering of the ES samples into two apparent sub-groups. From 
Fig. 3 normal bone and ES tumour bone are poorly differentiated by the first two components for each method 
alone. We interpret this as there being fewer bulk changes to the biochemical composition of the Ewing Sarcoma 
tumour than that observed in the infected Osteomyletis bone.
Although the unsupervised dimensionality reduction revealed poor differentiation in the first two compo-
nents of the samples (particularly of the normal and ES tumour), we speculated that higher order components, 
and combinations thereof, may allow the differentiation of the relative classes in supervised classification. We 
thus worked towards producing a predictive model capable of distinguishing the tissue classes and thus turned to 
supervised learning based classification. Supervised learning is the task of inferring a class from a set of labelled 
training data by fitting to a model that can predict the class of unknown labels of other objects (the test set). 
Stratified sampling was used to split the dataset into a training (67%) and test set (33%) maintaining the same 
ratio of class samples. Given the high dimensionality of the IR data set we first generated new features from the 
dimensionally reduced representations from PCA, Kernel PCA (sigmoid), isomap and factor analysis and stacked 
these together to generate a new reduced feature set. Training set data were then mapped onto these new dimen-
sionality reduced spaces. Taking the dimensionally reduced versions of the spectra we then trained machine 
learning models in the hopes of generating a predictive model able to differentiate tissue classes. As the most 
effective algorithm for a classification task cannot be discerned a priori the following classifiers were assessed: 
nearest neighbours, support vector machine with a linear kernel, support vector machine with a radial basis 
function kernel, Gaussian Process, decision tree, random forest, neural network, AdaBoost, Naive Bayes, quad-
ratic discriminant analysis, linear discriminant analysis, Nu-Support Vector classification, and Gradient Boosted 
classifier. Each was used as implemented using Scikit-Learn.
Through this analysis we identified a quadratic discriminant analysis (QDA) classifier as having the best dis-
criminating power against the external test set (80%) (see Table 3 for precision, recall and f1-scores for this clas-
sifier). QDA is a machine learning method which uses quadratic surface to separate classes from one another to 
produce a prediction model. Significantly this classification model was able to identify osteomyelitis with an 88% 
precision and 78% recall. The confusion matrix for this classifier is shown in Fig. 4. In comparison, the related 
random forest method had an lower accuracy compared to the QDA classifier in leave-one-out cross validation 
(60%) and had a poorer performance against the external test set (68%). In particular the random forest classifier 
struggled discerning normal and ES tissue from one another. Most classifiers struggled to discern the normal and 
Ewing sarcoma tissue sections from one another based on the dimensionality-reduced representations alone.
Discussion
Osteomyelitis is a disease caused by the development of inflammatory reaction in bone and bone marrow tis-
sue. The inflammation causes a specific or non-specific disturbance of the physicochemical balance in cells and 
affected tissues. It remains one of the most difficult to cure infectious diseases11. Unfortunately, the clinical, radio-
logical and pathological (Fig. 5) presentation of osteomyelitis can be very similar to malignant ES symptoms4,12,13.
Therefore, new methods for distinguishing osteomyelitis bone tissue and ES bone tissues are needed. The 
emerging diagnostic applications of FTIR spectroscopy are growing as the field matures and it has been applied 
successfully to the study of cancer14–18.
In this study FTIR spectroscopy was used to determine the chemical composition in normal, osteomyeli-
tis and ES bone tissue. We observed the biggest differences in the peaks positions and the values of maximum 
absorbance in the osteomyelitis samples compared to normal and ES samples (Figs 1 and 2, Table 1). It reflects 
the meaningful qualitative and quantitative differences in chemical composition between osteomyelitis tissue 
and other analysed tissues, but some differences were also observed between ES and normal bone tissues. The 
highest differences in osteomyelitis group were related to the values of maximum absorbance in the FTIR region 
Sample
Value of maximum 
absorbance Percentage [%] α-helix - 
β-sheet ratioα-helix β-sheet α-helix β-sheet
normal bone tissue sampled 
outside the area of ES infiltration 1.11 ± 0.52 1.39 ± 0.43 44.4 ± 47.31 55.6 ± 30.94 0.80 ± 0.02
ES bone tissue 0.15 ± 0.03* 0.21 ± 0.07* 41.66 ± 20.00 58.44 ± 33.33 0.71 ± 0.06*
Osteomyelitis bone tissue 0.02 ± 0.00* 0.05 ± 0.00* 28.57 ± 0.00* 71.43 ± 0.00* 0.78 ± 0.00*
Table 2. Maximum absorbance values for α-helix and β-sheet, percentage and ratio of protein α and β 
secondary structures. Value of peaks area, percentage and ratio of protein α and β secondary structures. 
*p < 0.05, vs. normal bone tissue sampled outside the area of ES infiltration.
precision recall f1-score
Normal 0.78 0.78 0.78
Ewing Sarcoma 0.75 0.86 0.80
Osteomyelitis 0.88 0.78 0.82
Table 3. Precision, recall and f1-score from the QDA classifier used in this work.
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corresponded to lipids functional groups (Figs 1 and 2, Table 1). The altered lipid content in this group, among 
other reasons, can be a result of increased concentration of lipid hydroperoxide (LOOH). This enzyme is one of 
the markers of oxidative stress19,20 and is responsible for the oxidative degradation of lipids to reactive aldehydes 
such as malondialdehyde and 4-hydroxynonenal21. The values of absorbance for aldehyde group at wavenumbers 
1740 cm−1 in FTIR spectra of osteomyelitis bone tissues are higher than the values of these peaks in other two 
groups. This is consistent with the presence of an active lipid peroxidation related to the inflammatory process in 
osteomyelitis affected bone. Moreover, changes in the chemical local microenvironment are dependent upon cell 
proliferative activity and cell cycle phase22, which may also explain some of the observed differences in lipid and 
protein contents seen in the analysed sample groups.
The different absorbance values for the FTIR region corresponding to amide II and amide I groups in the nor-
mal bone samples compared to ES and osteomyelitis bone tissues samples reflect the qualitative and quantitative 
dissimilarity in protein content between them. The deconvolution of the amide I FTIR region (Fig. 2) revealed the 
different number of bands compounds in the each of analysed bone samples. Furthermore, the α-helix/β-sheet 
ratio (Table 2) shows, that the secondary structure of proteins in normal bone tissue differs from that in the ES 
and osteomyelitis bone tissue. The highest value of α-helix - β-sheet ratio in normal bone tissue is significantly 
different than corresponding ratio value in ES and osteomyelitis bone samples (Table 2). The different protein 
profile in the analysed three classes of bone tissue is related to the different cellular and tissue composition of 
them. The common feature in osteomyelitis and Ewing sarcoma is an inflammatory infiltration of immunological 
cells such as lymphocytes, neutrophils, monocytes, platelets and others. This infiltration determines the different 
protein content in ES and osteomyelitis samples compare to normal bone tissue.
Figure 4. Confusion matrix of a QDA classifier applied to the dimensional reduced spectral data as validated 
against an external test set.
Figure 5. Ewing sarcoma (A) and osteomyelitis (B) in the light microscopy. Hematoxylin and eosin stained. E. 
Michalak.
www.nature.com/scientificreports/
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When a diagnosis error leads to incorrect or delayed treatment, or indeed no treatment at all, a patient’s condi-
tion can be worsened. The differential diagnosis of Ewing Sarcoma and osteomyelitis is challenging and misdiag-
nosis is well-known and can lead to adverse clinical outcomes. Early detection is crucial not only for ES diagnosis, 
where the delay of treatment may result in tumour dissemination with a significant worsening of prognosis, but 
also for osteomyelitis, where a delay of only 4 days in the diagnosis is a risk factor for long-term sequelae3. The 
application of FTIR spectroscopy to the study of malignant bone tumours and other bone pathologies remains 
unexplored. Given the natural, low incidence of both ES and osteomyelitis this work is limited by both its number 
of subjects including and retrospective character. Our findings, however, suggest that FTIR spectroscopy com-
bined with dimensionality reduction and machine learning methods can distinguish osteomyelitis bone tissue, 
Ewing Sarcoma and normal bone tissue from one another with a high degree of accuracy.
Conclusions
Supervised learning using a gradient boosted classifier was able to differentiate the Ewing sarcoma and osteo-
myelitis samples from one another with high accuracy. We propose, based on this small cohort study, that FTIR 
spectroscopy, alongside routine radiological and histopathological methods, may offer an additional, powerful 
and straightforward tool to distinguish ES and osteomyelitis. We are working to confirm the diagnostic in further, 
prospective studies with more numerous groups of patients.
References
 1. Raciborska, A. et al. Validation of a multi-modal treatment protocol for Ewing sarcoma a report from the polish pediatric oncology 
group. Pediatr Blood Cancer. 61(12), 2170–2174 (2014).
 2. Gutierrez, K. 78 Osteomyelitis, In. Long, S. S., Pickering, L. K. & Prober, C. G. Principles and Practice of Pediatric Infectious Diseases 
(Fourth Edition). Elsevier, 2012.
 3. Chiappini, E., Mastrangelo, G. & Lazzeri, S. A Case of Acute Osteomyelitis: An Update on Diagnosis and Treatment. Int J Environ 
Res Public Health. 13(6), E539 (2016).
 4. McCarville, M. B. et al. Distinguishing Osteomyelitis From Ewing Sarcoma on Radiography and MRI. AJR Am J Roentgenol. 205(3), 
640–651 (2015).
 5. Wald, N., Le Corre, Y., Martin, L., Mathieu, V. & Goormaghtigh, E. Infrared spectra of primary melanomas can predict response to 
chemotherapy: The example of dacarbazine. Biochim Biophys Acta. 1862(2), 174–181 (2016).
 6. Chaber, R. et al. Fourier Transform Infrared (FTIR) spectroscopy of paraffin and deparafinnized bone tissue samples as a diagnostic 
tool for Ewing sarcoma of bones. Infrared Phys Technol. 85, 364–371 (2017).
 7. Bellisola, G. & Sorio, C. Infrared spectroscopy and microscopy in cancer research and diagnosis. Am J Cancer Res. 2(1), 1–21 (2012).
 8. Chaber, R. et al. Application of infrared spectroscopy in the identification of Ewing sarcoma: A preliminary report. Infrared Phys 
Technol. 83, 200–205 (2017).
 9. Depciuch, J. et al. Comparing paraffined and deparaffinized breast cancer tissue samples and an analysis of Raman spectroscopy and 
infrared methods. Infrared Phys Technol. 76, 217–226 (2016).
 10. Bandyopadhyay, B., Pandey, P., Banerjee, P., Samanta, A. K. & Chakraborty, T. CH center dot center dot center dot O Interaction 
Lowers Hydrogen Transfer Barrier to Keto-Enol Tautomerization of beta-Cyclohexanedione: Combined Infrared Spectroscopic and 
Electronic Structure Calculation Study. J. Phys. Chem. A. 116(15), 3836–3845 (2012).
 11. Mandell, G., Bennett, J. E. & Dolin, R. Osteomyelitis, In. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious 
Diseases 7th Editiona. Philadelphia: Elsevier Inc. (2010).
 12. Mathur, K., Nazir, A. A., Sumathi, V. P. & Kumar, T. Ewing’s sarcoma masquerading as chronic osteomyelitis: a case report. Eur J 
Orthop Surg Traumatol. 16, 175–177 (2006).
 13. Durbin, M., Randall, R. L., James, M., Sudilovsky, D. & Zoger, S. Ewing’s sarcoma masquerading as osteomyelitis. Clin Orthop Relat 
Res. 357, 176–185 (1998).
 14. Zawlik, I. et al. FPA-FTIR Microspectroscopy for Monitoring Chemotherapy Efficacy in Triple-Negative Breast Cancer. Sci. Rep. 6, 
37333 (2016).
 15. Kaznowska, E. et al. The classification of lung cancers and their degree of malignancy by FTIR, PCA-LDA analysis, and a physics-
based computational model. Talanta 186, 337–345 (2018).
 16. Hands, J. R. et al. Brain tumour differentiation: rapid stratified serum diagnostics via attenuated total reflection Fourier-transform 
infrared spectroscopy. J Neurooncol. 127(3), 463–472 (2016).
 17. Liu, H., Su, Q., Sheng, D., Zheng, W. & Wang, X. Comparison of red blood cells from gastric cancer patients and healthy persons 
using FTIR spectroscopy. J Mol Struct. 1130, 33–37 (2017).
 18. Tfayli, A., Piot, O., Durlach, A., Bernard, P. & Manfait, M. Discriminating nevus and melanoma on paraffin-embedded skin biopsies 
using FTIR microspectroscopy. Biochimica et Biophysica Acta (BBA) 1724(3), 262–269 (2005).
 19. Tekin Koruk, S. et al. The activity of paraoxonase and arylesterase in patients with osteomyelitis. Scand J Clin Lab Invest. 72(7), 
513–517 (2012).
 20. Gaschler, M. M. & Stockwell, B. R. Lipid peroxidation in cell death. Biochem Biophys Res Commun. 482(3), 419–425 (2017).
 21. Spickett, C. M. The lipid peroxidation product 4-hydroxy-2-nonenal: Advances in chemistry and analysis. Redox Biology 1(1), 
145–152 (2013).
 22. Whelan, D. R., Bambery, K. R., Puskar, L., McNaughton, D. & Wood, B. R. Synchrotron Fourier transform infrared (FTIR) analysis 
of single living cells progressing through the cell cycle. Analyst. 138, 3891–3899 (2013).
 23. Delogne, C., Lawford, P. V., Habesch, S. M. & Carolan, V. A. Characterization of the calcification of cardiac valve bioprostheses by 
environmental scanning electron microscopy and vibrational spectroscopy. J. Microsc. 228, 62–77 (2007).
 24. Wong, P. T., Wong, R. K., Caputo, T. A., Godwin, T. A. & Rigas, B. Infrared spectroscopy of exfoliated human cervical cells: evidence 
of extensive structural changes during carcinogenesis. Proc. Natl. Acad. Sci. USA 88(24), 10988–10992 (1991).
 25. Kourkoumelis, N. & Tzaphlidou, M. Spectroscopic assessment of normal cortical bone: differences in relation to bone site and sex. 
Sci. World J. 10, 402–412 (2010).
 26. Neviliappan, S., Fang Kan, L., Tiang Lee Walter, T., Arulkumaran, S. & Wong, P. T. Infrared spectral features of exfoliated cervical 
cells, cervical adenocarcinoma tissue, and an adenocarcinoma cell line (SiSo). Gynecol. Oncol. 85(1), 170–174 (2002).
 27. Garip, S. & Severcan, F. Determination of simvastatin-induced changes in bone composition and structure by Fourier transform 
infrared spectroscopy in rat animal model. J. Pharm. Biomed. Anal. 52(4), 580–588 (2010).
 28. Theophanides, T. FT-IR Spectroscopy in Medicine, Infrared Spectroscopy –Life and Biomedical Sciences, http://www.intechopen.
com/books/infraredspectroscopy-life-and-biomedical-sciences, InTech. https://doi.org/10.5772/2655 (2012).
 29. Li, Q. B. Use of Fourier- transform infrared spectroscopy to rapidly diagnose gastric endoscopic biopsies. World J. Gastroenterol. 
11(25), 3842–3845 (2005).
www.nature.com/scientificreports/
8SCIENTIFIC REPORTs |  (2018) 8:15081  | DOI:10.1038/s41598-018-33470-3
Author Contributions
R.C. - research concept and design; collection and/or assembly of data; data analysis and interpretation; writing 
the article, final approval of the article C.J.A.- writing the article; data analysis and interpretation; critical revision 
of the article J.D. - writing the article; data analysis and interpretation; critical revision of the article K.Ł. - research 
concept and design; collection and/or assembly of data; data analysis and interpretation; writing the article A.R. - 
collection and/or assembly of data, critical revision of the article E.M. - collection and/or assembly of data; critical 
revision of the article J.C. - research concept and design; data analysis and interpretation; critical revision of the 
article; final approval of the article.
Additional Information
Competing Interests: The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2018
